Distinguished clinical development and medical affairs leader with over 25 years of international experience across therapeutic areas, including immunology, oncology, rare diseases, and cardiovascular medicine. He held senior roles at AstraZeneca and Sanofi, where he championed and pioneered the use of real-world evidence and digital platforms to speed clinical research and broaden market access for novel therapies.

A recognized expert in applying advanced data analytics to pharmaceutical development and regulatory strategy, Bernard has led initiatives that shortened clinical timelines, strengthened evidence generation, and enhanced payer and regulatory engagement.